Clinical Trial Update: Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial investigating BMS-754807 with letrozole or alone in hormone receptor-positive breast cancer with resistance to non-steroidal aromatase inhibitors;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BMS-754807 (BMS-754807)
• Letrozole (letrozole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-07-11